NCT00816114View on ClinicalTrials.gov

Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

June 8, 2005

Primary Completion Date

April 30, 2030

Study Completion Date

April 30, 2030

Conditions
Chronic Myelogenous Leukemia
Interventions
OTHER

Chart Review

Investigator review of MDACC CML patient charts.

Trial Locations (1)

77030

RECRUITING

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00816114 - Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial | Biotech Hunter | Biotech Hunter